Ralph Schwall

Medicine · Health Sciences

52h-index12.7kcitations109works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver physiology and pathology(42), TGF-β signaling in diseases(30), Growth Hormone and Insulin-like Growth Factors(12), Pancreatic and Hepatic Oncology Research(10), Cancer Cells and Metastasis(10)

Publications108 total

Supplementary Figure 3 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
2023Open Access
Supplementary Figures S1-S5 from Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer
2023Open Access
Supplementary Table 1 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
2023Open Access
Supplementary Table 1 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
2023Open Access
Data from Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer
2023Open Access
Data from Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer
2023Open Access
Supplementary Figure 3 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
2023Open Access
Supplementary Figure 1 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
2023Open Access
Supplementary Figure 1 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
2023Open Access
Supplementary Figure 2 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
2023Open Access
Data from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
2023Open Access
Supplementary Figures S1-S5 from Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer
2023Open Access
Data from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
2023Open Access
Supplementary Figure 2 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
2023Open Access
Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent
Proceedings of the National Academy of Sciences·2013· 239 citedOpen Access
Hepatocyte Growth Factor, a Determinant of Airspace Homeostasis in the Murine Lung
PLoS Genetics·2013· 58 citedOpen Access
Cooperation of the Agonistic DR5 Antibody Apomab with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve Survival
Clinical Cancer Research·2008· 53 cited
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate
Cancer Research·2008· 1.6k cited
Quantification of viable tumor microvascular characteristics by multispectral analysis
Magnetic Resonance in Medicine·2008· 52 citedOpen Access
One-armed 5D5 (OA5D5) is a potent humanized HGF-blocking anti-c-Met monovalent antibody that inhibits HGF-dependent activity in vitro and demonstrates anti-tumor efficacy in vivo
Cancer Research·2007· 7 cited
page 1 of 6Next →

Frequent Co-authors

Anthony J. Mason(10), Sharon Fong(7), Hartmut Koeppen(7), Avi Ashkenazi(4), David A. Lawrence(4), Debra L. Dugger(4), Ling Chang(4), Hongkui Jin(4), Renhui Yang(4), Elaine Mai(3), Klára Tótpál(3), Nerissa Mendoza(3), Dineli Wickramasinghe(3), Mark Merchant(3), Charles H. Schmelzer(3), G L Bennett(3), Jed Ross(3), Gail D. Lewis Phillips(2), Wai Lee Wong(2), Kenneth J. Hillan(2)